leadf
logo-loader
viewXpediator PLC

Xpediator raises dividend and says it is ready for Brexit

Trading is almost back to pre-coronavirus levels, according to the AIM-listed group

Xpediator PLC -

Xpediator PLC (LON:XPD), the freight forwarder and logistics group, said it is fully prepared for Brexit whatever the outcome as it posted an increase in first-half profits.

Trading is almost back to pre-coronavirus (COVID-19) levels, the AIM-listed group said, helped by good performances in central Europe and a recovery in the UK following the COVID-19 disruption.

Revenues dipped 3% to £99.6mln in the half-year to June 30, 2020, while profits rose by a third top £302,000 as the good performance in freight forwarding offset dips in affinity and warehousing, which were the arms most affected by COVID-19 restrictions.

Underlying profits ticked up to £2.1mln £2mln) and after good cash generation, Xpediator said it had raised its interim dividend by 60% to 0.45p.

In the results statement, Alex Borelli, Xpediator's chairman, said that the performance of the Freight Forwarding division was particularly impressive in Lithuania, Bulgaria, Estonia and Serbia in the first half while the group's domestic business in the UK showed strong margin growth.

Xpediator noted that a Brexit committee made up of the senior executives within the division was established in 2018 and has been meeting regularly to manage the project.

“Depending on the outcome of negotiations between now and January 2021 custom clearance activity may offer a significant opportunity for the division,” it added.

“We expect the full-year adjusted profit to be in line with or above the level achieved last year,” the results statement concluded.

Quick facts: Xpediator PLC

Price: 37 GBX

AIM:XPD
Market: AIM
Market Cap: £52.4 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Xpediator PLC named herein, including the promotion by the Company of Xpediator PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE jumps on AstraZeneca COVID-19 vaccine trial and easing...

FTSE 100 rallied in early trading on AstraZeneca’s COVID-19 vaccine trial and the easing of lockdown restrictions from December. London’s blue-chip index rose 20 to 6,371. AstraZeneca PLC (LON:AZN) announced that the coronavirus (COVID-19) vaccine it has developed with Oxford University was...

on 23/11/20

2 min read